Carnegie Mellon University researchers introduced ‘AggreBots’ — microscale living robots engineered from human lung cells. These biological robots exhibit customizable motility, promising future capabilities to navigate complex bodily environments for precise therapeutic or mechanical interventions. Published in Science Advances, the tissue engineering platform represents a novel convergence of synthetic biology and robotics.